Farmadosis accelerates abroad to reach 25 million by 2021
Spain’s Mallorca-based Farmadosis is forecasting 8.7% growth in 2021, equivalent to reaching $ 30.5 million (€ 25 million) in revenue over the same period. Those numbers would mean a fourfold increase in the company’s revenue from 2018, as the company explains.
The biotech company is currently embroiled in an international growth plan and plans to expand its presence in Costa Rica. At the same time, it also intends to expand into other countries like Chile, Mexico and the United States. The goal of this expansion plan is to work, both directly and indirectly, with customers to manufacture healthcare equipment and drug solutions.
In 2020, Farmadosis took control of Atepharma with the aim of strengthening its presence in the nursing home and social care sector. This company oversees the pharmaceutical care of 30,000 residents in Spain and will add an additional 15,000 people this year.
learn more about Farmadosis and its plans to expand and research the most important financial stocks with our companion app Born2Invest.
Farmadosis has developed its own software which facilitates the traceability of medication taken in nursing homes and socio-health centers.
Diversifying its market is also a goal for Farmadosis. The biotechnology company intends to expand its presence in the field of technology and thus not focus only on consumables. Indeed, the Balearic-based company has developed its own software which facilitates the traceability of medication taken in nursing homes and social and health centers.
In this regard, the company entered into several agreements in 2020 with foreign companies, such as Japanese Panasonic and Chinese Laoken, with the aim of providing specific distributors in which to include its own software.
On the other hand, the pandemic has not prevented Farmadosis from expanding its workforce to 53 employees in 2021. This figure means that it has increased its workforce by 33% over the past two years, a pace that the company claims it can accelerate in the months to come.
The Balearic Government has awarded Farmadosis a contract worth $ 672,200 (€ 549,900) for the acquisition of health and protection equipment against Covid-19
The company, headquartered in Palma and logistics headquarters in Terrassa (Barcelona), recently opened a new technological warehouse and another for healthcare equipment in Madrid. Farmadosis also plans to close a round table before the summer. In addition, last month the Balearic government awarded Farmadosis a contract worth $ 672,200 (€ 549,900) for the purchase of health and COVID-19 protection equipment.
(Featured Image by McRonny via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or associates. Please see our Warning for more information.
This article may include forward-looking statements. These forward-looking statements are generally identified by the words “believe”, “plan”, “estimate”, “become”, “plan”, “” and similar expressions. These forward-looking statements involve known and unknown risks and uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, be sure to read these important disclosures.
First published in PlantaDoce, a third party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we have made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this site. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for any losses caused by such reliance on the accuracy or reliability of the translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.